Clinical Diagnosis and Evaluation of Sinusitis in Adults
Am Fam Physician. 2007 Dec 1;76(11):1620-1624.
The guideline from the American Academy of Otolaryngology—Head and Neck Surgery on managing sinusitis in adults1 provides physicians with a clear definition of rhinosinusitis. The term rhinosinusitis is preferred because sinusitis almost always involves the nasal cavity.
Uncomplicated rhinosinusitis is defined as rhinosinusitis without clinically evident inf lammation outside the paranasal sinuses and nasal cavity at the time of diagnosis (e.g., no neurologic, ophthalmologic, or soft tissue involvement). Rhinosinusitis may be further classified by duration: acute (less than four weeks), subacute (four to 12 weeks), or chronic (more than 12 weeks, with or without acute exacerbations). Acute rhinosinusitis may be further classified as acute bacterial rhinosinusitis or viral rhinosinusitis. If four or more episodes of acute bacterial rhinosinusitis occur per year without persistent symptoms between episodes, the condition is termed recurrent acute rhinosinusitis.
Acute bacterial rhinosinusitis manifests as purulent (not clear) nasal drainage lasting up to four weeks that is accompanied by nasal obstruction; facial pain, pressure, or fullness; or both. Purulent nasal drainage as a sole criterion lacks sensitivity for distinguishing between viral and bacterial infection.2 If a patient meets diagnostic criteria for acute rhinosinusitis, radiologic imaging is not needed, thereby avoiding unnecessary delays in diagnosis and radiation exposures.3,4
Evaluation of acute bacterial rhinosinusitis should include pain assessment, and treatment may include analgesia and symptom relief. Adjunctive treatments that may help relieve symptoms include alpha-adrenergic decongestants, corticosteroids, saline irrigation, and mucolytics. However, none of these therapies have been approved by the U.S. Food and Drug Administration (FDA) to treat acute rhinosinusitis, and few data from controlled clinical studies support their use.
For selected adults with uncomplicated acute bacterial rhinosinusitis who have mild illness (i.e., mild pain and temperature less than 101° F [38.3° C]) and in whom follow-up can be assured, the guideline notes that antibiotics may be deferred and management may be limited to symptom relief and observation. Antibiotics should be initiated if the patient's condition fails to improve after seven days, or worsens at any time. Observing patients with uncomplicated acute bacterial rhinosinusitis is consistent with other practice guidelines.4-6
The rationale for recommending observation in patients with uncomplicated acute bacterial rhinosinusitis is based on randomized controlled trials (RCTs) that show a modest absolute increase in positive outcomes within seven to 12 days in patients taking antibiotics (absolute rate difference = 14 to 15 percent; number needed to treat = 7) compared with the high rate of spontaneous improvement in patients receiving placebo. However, after 14 or 15 days, the impact of antibiotic therapy is insignificant.7 Also, adverse events occur more often with antibiotics than with placebo (number needed to harm = 9).
If acute bacterial rhinosinusitis worsens or fails to improve during the seven-day interval, the physician should reassess the patient to confirm the diagnosis, exclude other causes of illness, and detect complications. If acute bacterial rhinosinusitis is confirmed, antibiotic therapy should be initiated. The recommendation to assess treatment failure seven days after initial diagnosis is based on clinical outcomes in RCTs demonstrating that seven to 12 days after trial enrollment, 73 percent of patients receiving placebo have clinical improvement; this increases to 85 percent when antibiotics are administered.7
Although dozens of RCTs have assessed the comparative effectiveness of antibiotics in adults with acute bacterial rhinosinusitis, no significant differences among antibiotics have been noted.8 As a result, if a decision is made to treat a patient with an antibiotic, amoxicillin should be the first-line therapy for most adults because of its safety, effectiveness, low cost, and narrow microbiologic spectrum.6,8-12 For patients allergic to penicillin, folate inhibitors (e.g., trimethoprim/sulfamethoxazole [Bactrim/Septra]) are cost-effective alternatives.9,10,13-15 The macrolide class of antibiotics may also be used in patients with penicillin allergy.
The choice of initial antibiotic therapy may also be affected by factors, such as recent antibiotic use; local antibiotic resistance patterns; dosing schedules; and children in the household who attend day care and are at increased risk of penicillin-resistant Streptococcus pneumoniae infection, for which high-dose amoxicillin is an option.
Educational tools such as laminated teaching cards or other visual aids summarizing diagnostic criteria and the typical clinical course of viral and acute bacterial rhinosinusitis may facilitate the differentiation of these conditions in busy clinical settings. The Centers for Disease Control and Prevention's Get Smart campaign has produced educational material that can help physicians clarify misconceptions about viral illness and nasal discharge.16 Potential barriers to patient observation can be overcome with educational pamphlets and information sheets that outline the favorable natural history of uncomplicated acute bacterial rhinosinusitis, the modest incremental benefit of antibiotics on clinical outcomes, and the potential adverse effects of oral antibiotics (including induced bacterial resistance).
Unanswered questions provide potential opportunities for research. These questions are addressed in the guideline. The full guideline is available for a limited time at http://www.entlink.net/qualityimprovement/Adult-Sinusitis.cfm.
REFERENCESshow all references
1. Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(suppl S):S1–31....
2. Lacroix JS, Ricchetti A, Lew D, Delhumeau C, Morabia A, Stalder H, et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Otolaryngol. 2002;122:192–6.
3. Balk EM, Zucker DR, Engels EA, Wong JB, Williams JW Jr, Lau J. Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med. 2001;16:701–11.
4. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. American Academy of Family Physicians, American College of Physicians—American Society of Internal Medicine, Centers for Diseases Control and Prevention, Infectious Diseases Society of America. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001;134:498–505.
5. Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al., for the EAACI. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005;60:583–601.
6. Snow V, Mottur-Pilson C, Gonzales R. American Academy of Family Physicians, American College of Physicians—American Society of Internal Medicine, Centers for Diseases Control and Prevention, Infectious Diseases Society of America. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med. 2001;134:518–20.
7. Rosenfeld RM, Singer M, Jones S. Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngol Head Neck Surg. 2007;137(suppl S):S32–45.
8. Williams JW Jr, Aguilar C, Cornell J, Chiquette ED, Makela M, Holleman DR, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2003(2):CD000243.
9. de Bock GH, Dekker FW, Stolk J, Springer MP, Kievit J, van Houwelingen JC. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol. 1997;50:881–90.
10. Lau J, Zucker D, Engels EA, Balk E, Barza M, Terrin N, et al. Diagnosis and treatment of acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ). 1999(9):1–5.
11. Low DE, Desrosiers M, McSherry J, Garber G, Williams JW Jr, Remy H, et al. A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ. 1997;156(suppl 6):S1–14.
12. Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, et al., for the Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis [Published correction appears in Otolaryngol Head Neck Surg 2004;130:794–6]. Otolaryngol Head Neck Surg. 2004;130(1 suppl)1–45.
13. de Ferranti SD, Ioannidis JP, Lau J, Anninger WV, Barza M. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ. 1998;317:632–7.
14. Institute for Clinical Systems Improvement. Acute Sinusitis in Adults. May 2004. Accessed online August 30, 2007, at: http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=5449.
15. Slavin RG, Spector SL, Bernstein IL, Kaliner MA, Kennedy DW, Virant FS, et al. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116(6 suppl):S13–47.
16. Centers for Disease Control and Prevention. Get smart: know when antibiotics work. Cough and cold medicines for children. Accessed August 30, 2007, at: http://www.cdc.gov/drugresistance/community/.
Copyright © 2007 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions